8-KEarnings & ResultsExhibits & Filings

Medtronic plc 8-K Report, Financial Results (Feb 21, 2017)

Filed February 21, 2017For Securities:MDT

Summary

Medtronic plc (MDT) filed an 8-K on February 21, 2017, to report its third quarter fiscal year 2017 financial results. The filing primarily consists of a press release and an earnings presentation, which are furnished as exhibits. Investors should review these documents for detailed performance information, including revenue, earnings per share, and segment performance. While this 8-K doesn't introduce new material events outside of the financial results announcement, it serves as the official channel for disseminating the company's quarterly performance to the public. The key takeaway for investors is the timing and availability of Medtronic's Q3 FY17 financial performance. The press release and presentation provide the most up-to-date information on the company's financial health and operational achievements during the reported quarter. Investors are encouraged to examine the furnished exhibits for a comprehensive understanding of Medtronic's financial standing and future outlook as presented by the company.

Key Highlights

  • 1Medtronic plc announced its third quarter fiscal year 2017 financial results on February 21, 2017.
  • 2The 8-K filing includes a press release detailing the company's financial performance.
  • 3An earnings presentation related to the Q3 FY17 results is also furnished with the filing.
  • 4These documents provide investors with key financial metrics and operational updates.
  • 5The filing date is February 20, 2017, with the event date being February 20, 2017, for the earnings release.
  • 6The furnished exhibits are crucial for a detailed understanding of the quarter's financial outcomes.

Frequently Asked Questions

The primary purpose of this 8-K filing is to officially announce and provide access to Medtronic's third quarter fiscal year 2017 financial results through a press release and an accompanying earnings presentation, which are furnished as exhibits.

The detailed financial results are contained within the press release (Exhibit 99.1) and the earnings presentation (Exhibit 99.2) that are furnished as part of this 8-K filing.

This particular 8-K filing focuses exclusively on the announcement of Medtronic's Q3 FY17 financial results. It does not appear to contain information about significant new business developments or strategic changes outside of the context of the quarterly performance.

The 'Event date' (February 20, 2017) likely refers to the date the financial results were determined or ready for release, while the 'Filed' date (February 20, 2017) is the actual date Medtronic submitted the 8-K report to the SEC. The press release itself is dated February 21, 2017, indicating the public announcement date.